Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tailor made: the art of therapeutic mRNA design
Mihir Metkar, Christopher S. Pepin, Melissa J. Moore
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 67-83
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Leveraging mRNA technology for antigen based immuno-oncology therapies
Charalampos S. Floudas, Siranush Sarkizova, Michele Ceccarelli, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010569-e010569
Open Access | Times Cited: 1
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities
Siyu Chen, Albertas Navickas, Hani Goodarzi
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 4, pp. 304-318
Open Access | Times Cited: 6
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation
Reni Kitte, Robert Serfling, Ulrich Blache, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 965-965
Open Access
Consistent features observed in structural probing data of eukaryotic RNAs
Kazuhiko Yamamura, Kiyoshi Asai, Junichi Iwakiri
NAR Genomics and Bioinformatics (2025) Vol. 7, Iss. 1
Open Access
UTR-Insight: integrating deep learning for efficient 5′ UTR discovery and design
Saichao Pan, Hanyu Wang, Hang Zhang, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Developing mRNA Nanomedicines with Advanced Targeting Functions
Ji Wang, Lijun Cai, Ning Li, et al.
Nano-Micro Letters (2025) Vol. 17, Iss. 1
Open Access
RNA-based therapies in liver metabolic diseases
Antonio Fontanellas, Pedro Berraondo, F Urigo, et al.
Gut (2025), pp. gutjnl-331742
Open Access
Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice
Xuan Du, Hideyuki Nakanishi, Takashi Yamada, et al.
Advanced Science (2025)
Open Access
mRNA therapy: A new frontier in regenerative medicine
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
gRNAde: Geometric Deep Learning for 3D RNA inverse design
Chaitanya K. Joshi, Arian R. Jamasb, Ramón Viñas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 528-528
Open Access | Times Cited: 3
Enhanced ER protein processing gene expression increases rAAV yield and full capsid ratio in HEK293 cells
Qiang Fu, Yongdan Wang, Jiansong Qin, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 3
Emerging mRNA Technology for Liver Disease Therapy
Ji Wang, Yile Fang, Zhiqiang Luo, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17378-17406
Closed Access | Times Cited: 2
Scarless circular mRNA-based CAR-T cell therapy elicits superior anti-tumor efficacy
Qinchao Hu, Hui Zhao, Kaicheng Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
gRNAde: A Geometric Deep Learning Pipeline for 3D RNA Inverse Design
Chaitanya K Joshi, Píetro Lió
Methods in molecular biology (2024), pp. 121-135
Closed Access | Times Cited: 2
Comprehensive translational profiling and STE AI uncover rapid control of protein biosynthesis during cell stress
Attila Horváth, Yoshika Janapala, Katrina Woodward, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7925-7946
Open Access | Times Cited: 1
Deep generative models generate mRNA sequences with enhanced translation capacity and stability
He Zhang, Hailong Liu, Yushan Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Optimization of the 5ʹ untranslated region of mRNA vaccines
Qi Ma, Zhang Xiao-guang, Jing Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Engineered mRNAs with stable structures minimize double-stranded RNA formation and increase protein expression
Qianshan Qin, Hua Yan, Weixiang Gao, et al.
Journal of Molecular Biology (2024), pp. 168822-168822
Closed Access | Times Cited: 1
Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation
Xiaoyan Ding, Yuxin Zhou, Jiuxiang He, et al.
(2024)
Open Access
Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation
Xiaoyan Ding, Yuxin Zhou, Jiuxiang He, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 432-432
Open Access
Page 1 - Next Page

Scroll to top